You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 IMRT studies in larynx tumors

From: Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer

  Patients (n) Tumor stage Chemotherapy LRC OS
Eisbruch[30] 11 n.a. n. a. 60% (3 yrs) n. a.
Yao[29] 33 n.a. n. a. 85% (2 yrs) n. a.
Lee[31] 20 III/IV: 100% 100% 90% (2 yrs) 69% (2 yrs)
Studer[28]* 58 I/II: 31% 85% 65% (3 yrs) 78% (3 yrs)
II/IVA: 69%
Nguyen[32] 8 III/IVA: 100% 100% 85.2% (2 yrs) n. a.
Current study 77 I/II: 54% 28% 76% (3 yrs) 81% (3 yrs)
II/IVA: 46% 79%
  1. LCR loco-regional control, OS overall survival, n. a. not applicable for laryngeal cancer exclusively.
  2. *small number of patients included in both series.